Dane Andreeff Purchases 167,000 Shares of Helius Medical Technologies, Inc. (HSDT) Stock

Helius Medical Technologies, Inc. (OTCMKTS:HSDT) Director Dane Andreeff acquired 167,000 shares of the company’s stock in a transaction on Monday, November 13th. The shares were purchased at an average cost of $2.58 per share, with a total value of $430,860.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Helius Medical Technologies, Inc. (OTCMKTS:HSDT) opened at $2.16 on Wednesday. Helius Medical Technologies, Inc. has a twelve month low of $1.29 and a twelve month high of $4.14.

TRADEMARK VIOLATION WARNING: “Dane Andreeff Purchases 167,000 Shares of Helius Medical Technologies, Inc. (HSDT) Stock” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.thestockobserver.com/2017/11/15/dane-andreeff-purchases-167000-shares-of-helius-medical-technologies-inc-hsdt-stock.html.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.

Receive News & Ratings for Helius Medical Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply